{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:51:00Z","timestamp":1761763860279},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6307,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1093\/annonc\/mdf282","type":"journal-article","created":{"date-parts":[[2002,11,7]],"date-time":"2002-11-07T02:18:26Z","timestamp":1036635506000},"page":"1616-1620","source":"Crossref","is-referenced-by-count":36,"title":["Routine chest X-rays have no additional value in the detectionof relapse during routine follow-up of patients treated with chemotherapy for disseminated non-seminomatous testicular cancer"],"prefix":"10.1016","volume":"13","author":[{"given":"J.A.","family":"Gietema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Meinardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.T.","family":"Sleijfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.T.A.","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdf282_bb0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199707243370406","article-title":"Testicular germ-cell cancer","volume":"337","author":"Bosl","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdf282_bb0015","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/bmj.322.7302.1583","article-title":"Regular review. Managing testicular cancer","volume":"322","author":"Dearnaley","year":"2001","journal-title":"BMJ"},{"key":"10.1093\/annonc\/mdf282_bb0020","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International Germ Cell Consensus Classification. A prognostic-factor based staging system for metastatic germ cell cancer by the International Germ Cell Cancer Collaboration Group (IGCCCG)","volume":"15","year":"1997","journal-title":"J Clin Oncol"},{"issue":"Suppl 12","key":"10.1093\/annonc\/mdf282_bb0025","first-page":"8","article-title":"Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience","volume":"19","author":"Motzer","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdf282_bb0030","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1200\/JCO.1991.9.9.1549","article-title":"Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma","volume":"9","author":"Harstrick","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf282_bb0035","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1200\/JCO.1998.16.7.2500","article-title":"Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor","volume":"16","author":"Loehrer","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf282_bb0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0090-4295(91)80151-V","article-title":"Predictive factors for effective salvage therapy of nonseminoma germ cell tumors of the testis","volume":"38","author":"Dimopoulos","year":"1991","journal-title":"Urology"},{"key":"10.1093\/annonc\/mdf282_bb0045","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1200\/JCO.1996.14.10.2638","article-title":"High-dose chemotherapy as salvage treatment in germ cell tumors: A multivariate analysis of prognostic factors","volume":"14","author":"Beyer","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf282_bb0050","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1200\/JCO.1996.14.4.1098","article-title":"High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity","volume":"14","author":"Motzer","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf282_bb0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-87-3-293","article-title":"Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer","volume":"87","author":"Einhorn","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdf282_bb0060","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1200\/JCO.1989.7.3.387","article-title":"Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol","volume":"7","author":"Einhorn","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf282_bb0065","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1200\/JCO.1993.11.4.598","article-title":"Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study","volume":"11","author":"Bajorin","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf282_bb0070","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/bjc.1998.587","volume":"78","author":"De Wit","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdf282_bb0075","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1200\/JCO.2001.19.6.1629","volume":"19","author":"De Wit","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf282_bb0080","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.1995.13.5.1188","article-title":"Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10-year experience","volume":"13","author":"Gels","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf282_bb0085","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1200\/JCO.2000.18.12.2413","article-title":"Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer","volume":"18","author":"Motzer","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf282_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1200\/JCO.2001.19.1.81","article-title":"Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer","volume":"19","author":"Rick","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf282_bb0095","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1126::AID-CNCR17>3.0.CO;2-8","article-title":"Cost-effectiveness of posttreatment surveillance after radiation therapy for early stage seminoma","volume":"82","author":"Buchholz","year":"1998","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf282_bb0100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0936-6555(05)80694-6","article-title":"Early detection of relapse after treatment for metastatic germ cell tumour of the testis: an exercise in medical audit","volume":"5","author":"Rathmell","year":"1993","journal-title":"Clin Oncol"},{"key":"10.1093\/annonc\/mdf282_bb0105","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1023\/A:1012464623057","article-title":"ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of mixed or non-seminomatous germ cell tumours (NSGCT)","volume":"12","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf282_bb0110","first-page":"1587","article-title":"Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial","volume":"271","author":"JAMA","year":"1994","journal-title":"The GIVIO Investigators"},{"key":"10.1093\/annonc\/mdf282_bb0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00000658-199807000-00009","article-title":"Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest X-ray, and colonoscopy","volume":"228","author":"Graham","year":"1998","journal-title":"Ann Surg"},{"key":"10.1093\/annonc\/mdf282_bb0120","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0959-8049(01)00066-1","article-title":"Value and cost evaluation of routine follow-up for patients with clinical stage I\/II endometrial cancer","volume":"37","author":"Morice","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdf282_bb0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10434-000-0009-x","article-title":"Primary extremity sarcoma: what is the appropriate follow-up?","volume":"7","author":"Whooley","year":"2000","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419637725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419637725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/13\/10\/1616\/400385\/mdf282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T07:34:05Z","timestamp":1582184045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419637725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S0923753419637725"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdf282","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}